More bad news about atrial fibrillation

European Heart Journal

Volumn 25, Issue 19, 2004, Pages 1670-1671

  Thijs, Vincent ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; XIMELAGATRAN;

AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; AUSTRIA; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN PERFUSION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG CONTRAINDICATION; EDITORIAL; HEART ATRIUM FIBRILLATION; HUMAN; NEUROLOGIC DISEASE; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REGISTER; STROKE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; HUMANS; MIDDLE AGED; MULTICENTER STUDIES; PROGNOSIS;

EID: 4644238041     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.08.005     Document Type: Editorial

References (14)

1. A. Ott, M.M. Breteler, and M.C. de Bruyne Atrial fibrillation and dementia in a population-based study. The Rotterdam study Stroke 28 2 1997 316 321
2. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 8 1991 983 988
3. H.J. Lin, P.A. Wolf, and M. Kelly-Hayes Stroke severity in atrial fibrillation. The Framingham study Stroke 27 10 1996 1760 1764
4. M. Lamassa, A. Di Carlo, and G. Pracucci Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project) Stroke 32 2 2001 392 398
5. H.P. Adams Jr., P.H. Davis, and E.C. Leira Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology 53 1 1999 126 131
6. C. Steger, A. Pratter, and M. Martinek-Bregel Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry Eur Heart J 25 2004 1734 1740
7. J. Leonardi-Bee, P.M. Bath, and S.J. Phillips Blood pressure and clinical outcomes in the International Stroke trial Stroke 33 5 2002 1315 1320
8. R. Saxena, S. Lewis, and E. Berge Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke trial Stroke 32 10 2001 2333 2337
9. B.M. Coull, L.S. Williams, and L.B. Goldstein Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association) Neurology 59 1 2002 13 22
10. C. Meisel, K. Prass, and J. Braun Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke Stroke 35 1 2004 2 6
11. H.C. Diener, J. Bogousslavsky, and L.M. Brass Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial Lancet 364 9431 2004 331 337
12. A.S. Go, E.M. Hylek, and Y. Chang Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? Jama 290 20 2003 2685 2692
13. S.B. Olsson Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial Lancet 362 9397 2003 1691 1698
14. H. Sievert, M.D. Lesh, and T. Trepels Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience Circulation 105 16 2002 1887 1889